Merck

SYLATRON

Manufacturer:

Merck

Sylatron HCPCS:

S0148

HCPCS Code Descriptor:

Injection, pegylated interferon alfa-2b, 10 mcg

Category:

S Code

Sylatron NDCs:

No actively aligned NDCs found

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Subcutaneous

Sylatron CPT Codes:

Potential CPT administration codes for Sylatron can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Sylatron:

SYLATRON is an Oncology drug manufactured by Merck and administered via the Subcutaneous route of administration. The S Code: S0148 is aligned to the drug SYLATRON.

ACCESS PRICING AND MORE BY REGISTERING

S0148 Added Date:

October 1, 2010

S0148 Effective Date:

October 1, 2010

S0148 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Sylatron billing and coding information.
Our team did not identify a source for Sylatron patient assistance information. Please reach out to our team if you feel that this is a mistake.
SYLATRON prescribing information can be found at the link below:
Information regarding SYLATRON’s side effects can be found at MedlinePlus